Q32 Bio
QTTB
QTTB
106 hedge funds and large institutions have $364M invested in Q32 Bio in 2020 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 27 increasing their positions, 38 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
3% less call options, than puts
Call options by funds: $1.98M | Put options by funds: $2.04M
29% less repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 38
37% less capital invested
Capital invested by funds: $574M → $364M (-$210M)
Holders
106
Holding in Top 10
2
Calls
$1.98M
Puts
$2.04M
Top Buyers
| 1 | +$11.7M | |
| 2 | +$1.89M | |
| 3 | +$1.3M | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$1.26M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$1M |
Top Sellers
| 1 | -$19.6M | |
| 2 | -$10M | |
| 3 | -$8.11M | |
| 4 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$5.34M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$4.98M |